What is Intact Vascular's business focus and history?
Intact Vascular is a medical device company based in Wayne, Pennsylvania, founded in 2011 by Robert M. Giasolli. It specializes in developing minimally invasive peripheral vascular products, including the Tack Endovascular System® for treating peripheral artery disease. The company was acquired by Philips in August 2020 for $275 million.
Intact Vascular Corporate Details & Core Services
Intact Vascular is a medical device company focused on developing minimally invasive peripheral vascular products, including the Tack Endovascular System® for treating peripheral artery disease.
Intact Vascular Contact Information & Official Links
What are Intact Vascular's Key Business Metrics & Stats?
No of employees 50
Founded year 2011
Type private
SAICS CODE 5047
NAICS Code 3391
Industry Medical Devices
Location Wayne, Pennsylvania, United States
Parent Company philips.com
Intact Vascular
Firmographic Snapshot
2026
2011
Founded Year
50
Global Employees
United States
Headquarters
Medical Devices Industry
Private
Type
Verified by
DexterAgent.ai
How much funding has Intact Vascular raised to date?
Name
Description
Funding Amount
USD 38.9 Million
Stage
Series B
Latest Valuation
275 Million (USD)
Lead Investor
New Enterprise Associates
Investors
New Enterprise Associates, Quaker Partners, H.I.G. BioVentures
What are Intact Vascular's Core Products?
Name
Description
Tack Endovascular System®
A device designed to optimize peripheral balloon angioplasty results in the treatment of peripheral artery disease.
What are the latest developments at Intact Vascular?
Date
Type
Description
August, 2020
Acquisition
Philips acquired Intact Vascular for $275 million.
Intact Vascular VS Acceleron Pharma VS Elixir Medical VS Shockwave Medical : 2026 Comparison
Feature
Intact Vascular
Acceleron Pharma
Elixir Medical
Shockwave Medical
Core Strengths Tack Endovascular System®
REBLOZYL (luspatercept-aamt), Sotatercept
DynamX Coronary Bioadaptor, LithiX Hertz Contact Lithotripsy Catheter, DESyne X2 Novolimus Eluting Coronary Stent System
Shockwave C2+ Coronary IVL Catheter, Shockwave L6 Peripheral IVL Catheter, Shockwave Javelin Peripheral IVL Catheter, Shockwave E8 Peripheral IVL Catheter, Reducer System
Founded Year 2011
2003
2005
2009
Stock Name/Ticker XLRN (NASDAQ)
Type private
private
private
private
Global Employees 50
312
1468
Revenue (Annual) $25 Million(2019)
$74.5 Million(2017)
$730.2 Million(2023)
Headquarters Wayne, Pennsylvania, United States
Cambridge, Massachusetts, United States
Milpitas, California, United States
Santa Clara, California, United States
Latest Valuation $275 Million
$11.5 Billion
$13.1 Billion
LATEST REVENUE (TRILLIONS USD)
EMPLOYEE COUNT (THOUSANDS)
INNOVATORS
VISIONARIES
DISRUPTORS
GIANTS
Acceleron Pharma
74.5 | 312
Shockwave Medical
730.2 | 1468
Competitive Landscape 2026
DexterAgent.ai
What are Intact Vascular's official legal and registration details?
Name
Description
Legal Name
Intact Vascular, Inc.
Cin number
GST number
Registration number
Who is in Intact Vascular's executive leadership team?
Name
Designation
CEO
Bruce J. Shook
Chief Medical Officer
Peter Schneider
Vice President of Clinical Affairs
Marc Penna
Where are Intact Vascular's primary office locations?
City
Country
Wayne
United States
What are the current business signals and market intelligence for Intact Vascular?
Pain points
Peripheral Artery Disease Treatment, Minimally Invasive Vascular Procedures
Sales motion
Direct Sales, Distributor Partnerships
Buyer Persona
Vascular Surgeons, Interventional Radiologists, Cardiologists
Type of customer
Hospitals, Clinics, Healthcare Providers
Key customer domain
What is Intact Vascular's annual revenue history?
Year
Revenue (USD)
2019
25 Million
What are Intact Vascular's risk management and compliance ratings?
GDPR RIsk
No
Privacy Risk
No
Company Ratings
Glassdoor Rating
Saas
No
Offline Stores
No
Service
No
Ecommerce
No
Exporter
No
Mobile App
No
Retail
No
B2B
Yes
B2C
No
Manufacturing
Yes
Wholesale
No
Importer
No
